Liquid Handling Market - Global Industry Size, Share, Trends, Competition, Opportunities and Forecast, Segmented by Type (Manual Liquid Handling, Automated Liquid Handling, Semi-Automated Liquid Handling), By Product (Automated Workstations, Pipettes, Dispensers, Burettes, Others), By Application (Drug Discovery, Cancer and Genomics Research, Clinical Diagnostics, Others), By End-User (Pharmaceutical and Biotechnology Industry, Contract Research Organization, Academic Institutes, and Others), By Region & Competition, 2020-2030F

Market Overview

Global Liquid Handling Market was valued at USD 2.12 billion in 2024 and is expected to reach USD 3.18 billion by 2030 with a CAGR of 7.12% during the forecast period. The global liquid handling market is undergoing significant transformation, driven by advancements in life sciences research, drug discovery, and laboratory automation. Liquid handling, a fundamental component of laboratory workflows, involves the precise measurement and transfer of liquids using manual or automated instruments. As laboratories continue to emphasize accuracy, reproducibility, and efficiency, the demand for advanced liquid handling systems has grown considerably. In July 2023, Revvity launched the Fontus Automated Liquid Handling Workstation, a state-of-the-art system combining advanced technologies from its existing platforms. This workstation is tailored to improve and accelerate workflows in next-generation sequencing (NGS) and diagnostic research applications.

The shift toward automation in laboratory settings is one of the key factors fueling this market. Automated liquid handling systems reduce the chances of human error, improve consistency, and increase throughput, making them indispensable in high-volume testing environments such as genomics, proteomics, and clinical diagnostics. These systems are particularly valuable in applications requiring high precision, such as next-generation sequencing, PCR, and cell-based assays. The increasing complexity of research, especially in areas such as personalized medicine and biotechnology, has created a need for liquid handling solutions that are not only accurate but also flexible and scalable. This has led to the integration of robotics and software into liquid handling platforms, enabling customization and seamless data management.

Emerging economies are also playing a crucial role in expanding the market landscape. Growing investments in healthcare infrastructure, increased funding for research and development, and the establishment of new laboratories are contributing to higher adoption rates of liquid handling systems in regions like Asia-Pacific and Latin America. The market is competitive and innovation-driven, with key players constantly striving to enhance performance, user-friendliness, and versatility. As the scientific community continues to pursue breakthroughs in diagnostics and therapeutics, liquid handling technologies will remain at the core of laboratory operations. The global liquid handling market is poised for steady growth, supported by technological evolution, rising research activity, and the ongoing need for accuracy and efficiency in laboratory environments.

Key Market Drivers

Growth in Life Sciences and Biotech Research

Growth in life sciences and biotechnology research plays a central role in driving the liquid handling market. For instance, in May 2024, Ohio was recognized for hosting the top two emerging biotech research hubs, highlighting the state’s growing prominence and investment in biotechnology innovation and development. As scientific investigations become more advanced, laboratories require tools that support precise, reliable, and high-throughput workflows. Liquid handling systems are vital for critical applications such as genomics, proteomics, cell biology, and drug discovery, where even minor errors in reagent volumes can lead to inconsistent or invalid results. Biotechnology companies and academic institutions are increasingly investing in research related to personalized medicine, regenerative therapies, and synthetic biology. These areas demand complex and sensitive assays that depend on accurate liquid transfer. Manual pipetting often falls short in terms of reproducibility and scalability, prompting a shift toward semi-automated and fully automated liquid handling platforms.  In drug development, the need to screen thousands of compounds against biological targets has pushed the adoption of robotic liquid handling systems. These systems enable rapid sample preparation, reduce human error, and support miniaturization, which saves on reagent costs. Research involving CRISPR, gene editing, and high-throughput sequencing also relies on advanced liquid handling to manage large volumes of data and samples efficiently.

Academic research institutions and public health laboratories are expanding their infrastructure to meet the growing demand for molecular diagnostics and vaccine research. This expansion increases the need for efficient, scalable liquid handling technologies. As life sciences research becomes more data-driven and interdisciplinary, the role of precise, automated liquid handling systems continues to grow, making them an indispensable part of modern laboratories.

R&D Investments by Pharmaceutical and Biotech Companies

R&D investments by pharmaceutical and biotechnology companies are a major force shaping the growth of the liquid handling market. For instance, in May 2025, KPBMA highlighted Korea’s leadership in drug discovery, attributing it to consistent and strong R&D investments. This unwavering commitment to research drives innovation, advances pharmaceutical development, and strengthens Korea’s position as a global leader in the drug discovery sector. As the race for drug innovation intensifies, these companies are channeling substantial resources into research to discover new therapeutics, improve existing treatments, and develop novel diagnostic tools. This surge in R&D activity demands precision, speed, and reproducibility—key requirements that liquid handling systems are designed to fulfill. In early-stage drug discovery, high-throughput screening involves testing thousands of compounds against biological targets. Automated liquid handling platforms streamline this process by enabling fast and accurate dispensing of reagents and samples. These systems reduce the time needed for manual pipetting and enhance data reliability, which is critical when evaluating potential drug candidates.

Biopharmaceutical companies are also exploring complex biologics, including monoclonal antibodies, cell therapies, and RNA-based treatments. These products require specialized workflows and sensitive liquid handling steps. Investments in R&D push companies to adopt advanced systems that can handle small volumes, maintain sterility, and ensure consistency across batches. Clinical trials represent another area where automated liquid handling is gaining traction. Sample preparation, bioanalytical testing, and biomarker analysis are all dependent on efficient liquid management. As regulatory expectations increase, companies need tools that support compliance and traceability while maintaining high throughput. Growing R&D pipelines, strategic collaborations, and the pursuit of innovation continue to drive demand for cutting-edge laboratory technologies. Liquid handling systems, integrated with robotics and data software, are becoming indispensable tools in helping pharmaceutical and biotech firms bring new therapies to market faster and more efficiently.

Growth in Personalized and Precision Medicine

The rise of personalized and precision medicine is significantly influencing the liquid handling market. This approach to healthcare focuses on tailoring treatments to individual patients based on genetic, environmental, and lifestyle factors. It demands a high level of accuracy and customization in laboratory workflows, which in turn requires advanced liquid handling technologies. In precision medicine, even small variations in sample volume or reagent concentration can impact the reliability of diagnostic tests and therapeutic outcomes. Liquid handling systems ensure consistency and precision in tasks such as DNA extraction, PCR setup, and next-generation sequencing. These processes are central to identifying genetic markers and developing targeted therapies. Healthcare providers and research organizations are increasing their use of molecular diagnostics to stratify patients and predict treatment responses. Automated liquid handling platforms play a vital role in processing these diagnostic tests at scale while maintaining accuracy and efficiency. They support high-throughput operations and reduce human error, which is essential when handling sensitive genetic data. Pharmaceutical and biotech companies are developing therapies that target specific patient subgroups. This trend is expanding the need for flexible liquid handling solutions that can manage small batch sizes and varied protocols. Manual methods are often insufficient for the complexity and volume of work required in personalized medicine.

As personalized and precision medicine continues to grow, laboratories must adopt technologies that support scalable and reliable operations. Liquid handling systems meet these demands by enabling repeatable, automated workflows that align with the evolving standards of modern medical research and patient care.

Download Free Sample Report

Key Market Challenges

Complexity of Operation and Integration

The complexity of operation and integration is a notable challenge in the liquid handling market. As laboratories adopt automated systems, they often face difficulties in configuring and operating these technologies effectively. Advanced liquid handling platforms typically require technical knowledge to set up protocols, troubleshoot errors, and maintain consistent performance. Not all laboratory staff are trained in operating such equipment, which can lead to inefficiencies, increased training time, or underutilization of the system.

Integrating liquid handling systems with existing laboratory infrastructure presents another layer of complexity. These systems must often communicate with laboratory information management systems (LIMS), robotic arms, and data analysis software. Ensuring seamless compatibility can be challenging, especially when different components are sourced from multiple vendors. Customization and software configuration may be required, which adds time and cost to the implementation process. Frequent updates in software and firmware can also pose operational challenges. Laboratories need to ensure that updates do not disrupt workflows or cause incompatibility with legacy systems. Maintenance personnel must stay current with changing technology standards to avoid downtime or errors during integration. Misalignment between user needs and system capabilities may lead to inefficiencies or errors in sample handling. Systems not properly configured for specific applications can produce inconsistent results, which compromises the quality and reliability of research. This complexity can discourage adoption, especially in settings with limited technical support. Simplifying user interfaces, offering better training resources, and improving interoperability with other lab systems are crucial to addressing this barrier and promoting broader use of automated liquid handling solutions.

High Capital Investment

High capital investment remains one of the most significant barriers to the widespread adoption of advanced liquid handling systems. These technologies, particularly automated platforms, involve substantial upfront costs that include the purchase of equipment, setup, integration with existing laboratory systems, and operator training. For many research institutions, especially those in developing regions or smaller laboratories with limited budgets, this financial requirement can delay or prevent adoption altogether. The initial expenditure is not limited to the core equipment. It also includes expenses related to software, consumables, maintenance contracts, and regular calibration. These ongoing costs can be difficult to sustain for facilities with fluctuating funding or those dependent on grants. Laboratories may opt to continue using manual pipetting methods, despite their limitations, to avoid these financial burdens.

High-throughput research facilities or large pharmaceutical companies are better positioned to absorb these costs, given the scale of their operations and the efficiency gains automated systems offer. However, smaller academic or diagnostic labs often face tough decisions between investing in automation or allocating funds to other research priorities. The return on investment from automated liquid handling can be significant in terms of labor savings, accuracy, and reproducibility, but the long payback period is a concern for many stakeholders. Financial constraints can slow down technological adoption, limit innovation, and widen the gap between high-resource and low-resource laboratories. To address this challenge, the market may benefit from scalable solutions, leasing options, or modular systems that allow gradual upgrades without a large one-time investment.

Key Market Trends

Growth in Point-of-Care and Decentralized Testing

The expansion of point-of-care (POC) and decentralized testing is significantly influencing the liquid handling market. As healthcare systems aim to provide rapid diagnostics closer to patients, there is a growing demand for compact, automated liquid handling solutions that can operate outside traditional laboratory environments. POC testing enables immediate clinical decisions by delivering diagnostic results at the patient's location, such as clinics, pharmacies, or homes. This shift reduces the reliance on centralized laboratories and accelerates treatment initiation. To support this model, liquid handling systems must be portable, user-friendly, and capable of precise sample processing in varied settings. The COVID-19 pandemic underscored the necessity for decentralized testing, leading to increased investments in POC technologies. Governments and healthcare providers recognized the value of rapid, on-site diagnostics in managing infectious diseases, prompting the development of advanced liquid handling devices tailored for POC applications.

In regions with limited access to centralized healthcare facilities, decentralized testing offers a practical solution for disease monitoring and management. Liquid handling systems designed for these environments must be robust, require minimal maintenance, and function reliably under diverse conditions. The integration of microfluidics and lab-on-a-chip technologies into POC devices has enhanced their capabilities, allowing for the handling of minute sample volumes with high precision. These innovations contribute to the efficiency and accuracy of decentralized diagnostic processes. As the healthcare landscape continues to evolve towards more patient-centric models, the demand for adaptable liquid handling solutions in POC and decentralized settings is expected to grow, driving innovation and expansion in the market..

Miniaturization and Microfluidics

Miniaturization and microfluidics are reshaping the liquid handling market by enabling laboratories to perform complex tasks with smaller volumes of reagents and samples. This trend addresses the need for cost-effective, high-precision workflows in areas such as drug discovery, genomics, and diagnostic testing. By working with nano-liter or even pico-liter volumes, researchers can reduce reagent consumption, lower operational costs, and increase throughput. Microfluidic systems, which manipulate tiny fluid volumes through channels on a chip, offer enhanced control over liquid movement and mixing. These systems support highly parallelized experiments, which are crucial in high-throughput screening and multiplex assays. Their precision makes them ideal for handling rare or precious samples, such as single-cell or DNA analysis, where even a small loss can impact results.

In the pharmaceutical industry, miniaturized liquid handling is playing a key role in compound screening and early-stage drug development. It allows researchers to test a greater number of compounds using fewer materials, which speeds up the identification of potential drug candidates. The reduced reaction volumes also facilitate faster thermal and chemical reactions, improving overall efficiency. For diagnostic labs, microfluidics enables compact, portable platforms that can deliver rapid results with minimal infrastructure. These devices are increasingly being used in point-of-care testing and resource-limited settings. As laboratories strive for greater precision and scalability, the demand for liquid handling systems that support miniaturization and microfluidic integration is growing. This trend is expected to continue as innovation focuses on reducing sample volumes while maintaining or improving analytical performance.

Segmental Insights

Type Insights

Based on type, Automated liquid handling currently holds the largest share of the market. High-throughput applications in drug discovery, genomics and clinical diagnostics demand accuracy, speed and reproducibility that manual pipetting cannot consistently deliver. Fully automated platforms minimize human error, accelerate sample throughput and offer integrated workflows—qualities critical in pharmaceutical R&D and large diagnostic labs. Semi-automated systems bridge the gap between manual and fully automated approaches, but they still require significant user intervention, limiting throughput gains. Manual liquid handling remains important for low-volume labs or bespoke protocols, but it cannot match the scalability and data integrity of automated instruments. As organizations prioritize efficiency, data quality and regulatory compliance, investment continues to skew toward fully automated solutions, cementing their dominance in the liquid handling market.  

Product Insights

Based on product, automated workstations dominate the market. These systems are preferred because they offer high precision, reproducibility, and scalability needed for modern laboratory workflows. Automated workstations are capable of handling complex tasks such as high-throughput screening, assay preparation, and sample processing with minimal human intervention, reducing errors and increasing efficiency. Pipettes, while widely used, especially in manual settings, cannot match the throughput or consistency of automated systems in large-scale operations. Dispensers and burettes are more specialized or manual tools suited for simpler liquid transfer tasks but lack automation capabilities essential for rapid, reproducible workflows. Automated workstations integrate multiple functions and often connect with software for protocol programming and data management. This makes them indispensable in pharmaceutical research, clinical diagnostics, and genomics, where accuracy and speed are paramount. The ongoing trend toward laboratory automation further reinforces the dominance of automated workstations in the liquid handling market.

Download Free Sample Report

Regional Insights

North America dominates the global liquid handling market due to several interrelated factors. The region hosts a significant number of leading pharmaceutical, biotechnology, and academic research institutions that heavily invest in advanced laboratory technologies. High funding levels for research and development activities support the adoption of automated liquid handling systems, which enhance efficiency, accuracy, and throughput. The presence of key market players and technology innovators in North America drives continuous improvements and availability of cutting-edge liquid handling solutions. These companies often collaborate with research institutions, facilitating faster adoption of new technologies. Regulatory frameworks in North America emphasize strict quality control and compliance standards, especially in pharmaceuticals and clinical diagnostics. This creates strong demand for precise, reliable liquid handling instruments capable of meeting stringent validation and reproducibility requirements.

Healthcare infrastructure is well-developed, with numerous clinical and diagnostic laboratories adopting automation to manage increasing testing volumes efficiently. The growing focus on personalized medicine, genomics, and high-throughput screening further fuels demand for sophisticated liquid handling systems. The region benefits from skilled technical workforce and robust supply chains, ensuring efficient deployment, maintenance, and support for liquid handling instruments. Together, these factors establish North America as the dominant market for liquid handling technologies worldwide.

Recent Developments

• In May 2023, Opentrons launched the Flex robot, an affordable, user-friendly liquid-handling system. Designed to democratize advanced lab automation, it makes sophisticated robotic technology accessible to labs of all sizes, broadening its impact across the research community.
• In March 2023, Eppendorf SE introduced the new generation of epMotion, an automated liquid handling portfolio designed to deliver improved precision, accuracy, and an enhanced user experience. This upgrade aims to meet evolving laboratory needs by providing reliable, efficient, and user-friendly automation solutions for diverse research and clinical applications.
• In December 2023, Hudson Robotics and Art Robbins Instruments, a global lab automation provider, acquired Tomtec Inc. Tomtec specializes in automated liquid handling instruments used mainly for sample preparation in mass spectrometry, enhancing the acquiring companies’ capabilities in advanced laboratory automation solutions.
• In February 2022, SPT Labtech launched the innovative Firefly liquid handling platform for next-generation sequencing library preparation. They also introduced the Apricot DC1, a versatile 4-in-1 automated liquid handling system. Both platforms were unveiled at the Society for Laboratory Automation and Screening (SLAS) 2022 International Conference and Expo, showcasing advanced solutions for laboratory automation.

Key Market Players

• Agilent Technologies
• Aurora Biomed, Inc.
• AUTOGEN, INC.
• Danaher Corporation
• BioTek Instruments, Inc.
• Analytik Jena AG  
• Corning Incorporated 
• Eppendorf AG     
• Formulatrix, Inc.   
• Gilson, Inc. 

Report Scope:

In this report, the Global Liquid Handling Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Liquid Handling Market, By Type:

o   Manual Liquid Handling

o   Automated Liquid Handling

o   Semi-Automated Liquid Handling

• Liquid Handling Market, By Product:

o   Automated Workstations

o   Pipettes

o   Dispensers

o   Burettes

o   Others     

• Liquid Handling Market, By Application:

o   Drug Discovery

o   Cancer and Genomics Research

o   Clinical Diagnostics

o   Others

• Liquid Handling Market, By End-User:

o   Pharmaceutical and Biotechnology Industry

o   Contract Research Organization

o   Academic Institutes

o   Others

• Liquid Handling Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global •       Liquid Handling Market.

Available Customizations:

Global Liquid Handling Market report with the given market data, TechSci Research, offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).